Darmiyan
YC S17San Francisco, US · Founded 2016 · Delaware corporation · 8 employees · 4 known investors
Darmiyan develops medical AI and brain imaging software for early detection and monitoring of neurodegenerative diseases, particularly Alzheimer's. The platform targets healthcare providers, patients, and pharmaceutical companies seeking to advance brain health and disease prevention.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesArtificial IntelligenceMachine LearningHealth TechDiagnosticsUnited States of AmericaAmerica / Canada
Founders & leadership· Y Combinator alumni (S17)
Darmiyan was founded in 2016 by Padideh Kamali-Zare and Kaveh Vejdani.
PK
Padideh Kamali-ZareinFounderPadideh Kamali-Zare holds a Ph.D. in Biological Physics from KTH and completed a postdoctoral position in computational neuroscience at NYU. She founded Darmiyan to develop early diagnostic tools for Alzheimer's disease.
KV
Kaveh VejdaniinFounder/Chief Medical and Technology Officer
Board
ST
Shirai TakehiroBoard director
Investors · 4
Reported raises · per SEC filings
Form D private placements$10M disclosed across 2 rounds · 2020–2023
▶$3.5MraisedOct 2023 · 5 investors · Other TechnologyRule 506(b)
▶$3.5MraisedOct 2023 · 5 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Kaveh VejdaniDirector
- Takehiro ShiraiDirector
- Padideh Kamali-ZareExecutive Officer
- Offering amount
- $3.5M
- Amount sold
- $3.5M
- First sale
- Oct 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.4MraisedApr 2020 · 32 investors · BiotechnologyRule 506(b)
▶$6.4MraisedApr 2020 · 32 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Padideh Kamali-ZareExecutive Officer, Director
- Shirai TakehiroDirector
- Kaveh VejdaniExecutive Officer, Director
- Offering amount
- $9.7M
- Amount sold
- $6.4M
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Darmiyan do?
- Darmiyan develops medical AI and brain imaging software for early detection and monitoring of neurodegenerative diseases, particularly Alzheimer's. The platform targets healthcare providers, patients, and pharmaceutical companies seeking to advance brain health and disease prevention.
- Who founded Darmiyan?
- Darmiyan was founded by Padideh Kamali-Zare, Kaveh Vejdani in 2016.
- Who are Darmiyan's investors?
- Darmiyan's investors include AAF Management Ltd., Eisai Innovation, Inc., Y Combinator, Thrive Capital.
- How much funding has Darmiyan raised?
- Darmiyan has disclosed $10M raised across 2 rounds.
- Where is Darmiyan headquartered?
- Darmiyan is headquartered in San Francisco, US.